| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | Common Stock | Options Exercise | $446K | +5.49K | +27.95% | $81.29 | 25.1K | Jan 7, 2025 | Direct | F1 |
| transaction | RVTY | Common Stock | Sale | -$282K | -2.43K | -9.66% | $116.13 | 22.7K | Jan 7, 2025 | Direct | F2, F3 |
| transaction | RVTY | Common Stock | Sale | -$280K | -2.39K | -10.51% | $117.14 | 20.3K | Jan 7, 2025 | Direct | F2, F4 |
| transaction | RVTY | Common Stock | Sale | -$55.8K | -474 | -2.33% | $117.79 | 19.9K | Jan 7, 2025 | Direct | F2, F5 |
| transaction | RVTY | Common Stock | Sale | -$23.8K | -200 | -1.01% | $118.92 | 19.7K | Jan 7, 2025 | Direct | F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | NQ Stock Option (right to buy) | Options Exercise | $0 | +5.49K | $0.00 | 0 | Jan 7, 2025 | Common Stock | 5.49K | $81.29 | Direct | F7 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The Exercise Price included on the Form 4 filed on February 1, 2018 for the Reporting Person was incorrectly reported due to administrative error. |
| F2 | The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024. |
| F3 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $115.62 to $116.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $116.69 to $117.60. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F5 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $117.71 to $117.88. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F6 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $118.84 to $119.00. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F7 | This option became exercisable in three equal annual installments beginning on January 30, 2019, which was the first anniversary of the date on which the option was granted. |
Senior Vice President, Global Operations